Intranasal budesonide given for 6 weeks benefits children with mild obstructive sleep apnea syndrome (OSAS), according to a report in the July Pediatrics.
Reuters Health Information
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines